| Englischer Name | Forschungscode | Forschungsphase | Firma | Indikationen | Klinische Studie |
|---|---|---|---|---|---|
| Oral alkaline phosphatase (Synthetic Biologics) | SYN-020 | Phase 1 Clinical | Massachusetts General Hospital, Theriva Biologics Inc | Celiac Disease; Enteritis; Inflammatory Bowel Diseases; Metabolic Syndrome | Details |